ScholarIQanswers from OpenAlex & ORCID
Michael E. Farkouh
ResearcherPublications, citations & collaboration network
Michael E. Farkouh is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael E. Farkouh have?
ScholarIQindexed works
Michael E. Farkouh has 674 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael E. Farkouh have?
ScholarIQcitation count
Michael E. Farkouh has 29,465 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael E. Farkouh?
ScholarIQh-index
Michael E. Farkouh has an h-index of 82 in OpenAlex.
What is the i10-index of Michael E. Farkouh?
ScholarIQi10-index
Michael E. Farkouh has an i10-index of 280 in OpenAlex.
What is the ORCID of Michael E. Farkouh?
ScholarIQorcid
The ORCID for Michael E. Farkouh is on the source record.
What is the OpenAlex record for Michael E. Farkouh?
ScholarIQopenalex
The OpenAlex for Michael E. Farkouh is on the source record.
What are the most-cited papers on Michael E. Farkouh?
ScholarIQmost cited works
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
Stuart J. Head, Milan Milojevic, Joost Daemen, Jung‐Min Ahn, Eric Boersma, Evald Høj Christiansen, Michaël Domanski, Michael E. Farkouh, Marcus Flather, Valentı́n Fuster, Mark A. Hlatky, Niels Ramsing Holm, Whady Hueb, Masoor Kamalesh, Young‐Hak Kim, Timo Mäkikallio, Friedrich W. Mohr, Grigorios Papageorgiou, Seung‐Jung Park, Alfredo E. Rodríguez, Joseph F. Sabik, Rod Stables, Gregg W. Stone, Patrick W. Serruys, A. Pieter Kappetein
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Subodh Verma, C. David Mazer, Andrew T. Yan, Tamique Mason, Vinay Garg, Hwee Teoh, Fei Zuo, Adrian Quan, Michael E. Farkouh, David Fitchett, Shaun G. Goodman, Ronald Goldenberg, Mohammed Al‐Omran, Richard E. Gilbert, Deepak L. Bhatt, Lawrence A. Leiter, Peter Jüni, Bernard Zinman, Kim A. Connelly, For the EMPA-HEART CardioLink-6 Investigators
AKI and Long-Term Risk for Cardiovascular Events and Mortality
Ayodele Odutayo, Christopher X. Wong, Michael E. Farkouh, Douglas G. Altman, Sally Hopewell, Connor A. Emdin, Benjamin H.M. Hunn
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis
Jeffrey D. Greenberg, Joel M. Kremer, Jeffrey R. Curtis, Marc C. Hochberg, George Reed, Peter Tsao, Michael E. Farkouh, Adeel Nasir, Soko Setoguchi, Daniel H. Solomon